R
Rhonda M. Cooper-DeHoff
Researcher at University of Florida
Publications - 270
Citations - 12399
Rhonda M. Cooper-DeHoff is an academic researcher from University of Florida. The author has contributed to research in topics: Blood pressure & Coronary artery disease. The author has an hindex of 51, co-authored 246 publications receiving 10876 citations. Previous affiliations of Rhonda M. Cooper-DeHoff include University of Texas Health Science Center at Houston & AstraZeneca.
Papers
More filters
Journal ArticleDOI
A Calcium Antagonist vs a Non-Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial
Carl J. Pepine,Eileen M. Handberg,Rhonda M. Cooper-DeHoff,Ronald G. Marks,Peter R. Kowey,Franz H. Messerli,Giuseppe Mancia,Jose L. Cangiano,David Garcia-Barreto,Matyas Keltai,Serap Erdine,Heather A. Bristol,H Robert Kolb,George L. Bakris,Jerome D. Cohen,William W. Parmley +15 more
TL;DR: The verapamil-trandolapril- based strategy was as clinically effective as the atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients, and was also recommended for patients with heart failure, diabetes, or renal impairment.
Journal ArticleDOI
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
Rhonda M. Cooper-DeHoff,Yan Gong,Eileen M. Handberg,Anthony A. Bavry,Scott J. Denardo,George L. Bakris,Carl J. Pepine +6 more
TL;DR: Tight control of systolic BP among patients with diabetes and CAD was not associated with improved cardiovascular outcomes compared with usual control, and little difference existed between those withUsually control and those with tight control.
Journal ArticleDOI
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation study and the St James Women Take Heart Project.
Martha Gulati,Rhonda M. Cooper-DeHoff,Candace K. McClure,B. Delia Johnson,Leslee J. Shaw,Eileen M. Handberg,Issam Zineh,Sheryl F. Kelsey,Morton F. Arnsdorf,Henry R. Black,Carl J. Pepine,C. Noel Bairey Merz +11 more
TL;DR: Women with symptoms and signs suggestive of ischemia but without obstructive CAD are at elevated risk for cardiovascular events compared with asymptomatic community-based women.
Journal ArticleDOI
Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival : Results from the National Institutes of Health-National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation
Leslee J. Shaw,C. Noel Bairey Merz,Ricardo Azziz,Frank Z. Stanczyk,George Sopko,Glenn D. Braunstein,Sheryl F. Kelsey,Kevin E. Kip,Rhonda M. Cooper-DeHoff,B. Delia Johnson,Viola Vaccarino,Steven E. Reis,Vera Bittner,T. Keta Hodgson,William J. Rogers,Carl J. Pepine +15 more
TL;DR: Among postmenopausal women evaluated for suspected ischemia, clinical features of PCOS are associated with more angiographic coronary artery disease and worsening CV event-free survival.
Journal ArticleDOI
Obesity Paradox in Patients with Hypertension and Coronary Artery Disease
Seth Uretsky,Franz H. Messerli,Sripal Bangalore,Annette Champion,Rhonda M. Cooper-DeHoff,Qian Zhou,Carl J. Pepine +6 more
TL;DR: In a population with hypertension and coronary artery disease, overweight and obese patients had a decreased rate of primary outcome compared with patients of normal weight, which was driven primarily by a decreased risk of all-cause mortality.